can glp 1 be used in type 1 diabetes GLP-1 receptor agonists are increasingly to treat 2 and obesity, and trials have shown reductions cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Ozempic and Other Off-Label Drugs
Description
Weight loss of 5-7% can significantly improve liver steatosis, whilst losses exceeding 10% may lead to improvements in inflammation and fibrosis
Mechanisms of action GLP-1RAs have become notable for their ability to reduce glucose levels and their emerging function as anti-inflammatory agents
The percentage of participants who discontinued the medication due to AE ranged between 20 and 29%
But unfortunately, BMI is still used in clinical settings, especially to prescribe GLP-1s
La eleccin del medicamento depende del historial mdico, la condicin actual y los objetivos del tratamiento
